Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Michael Leapman MD

Michael Leapman MD

Urologic Oncology Fellow, University of California, San Francisco, California

Michael Leapman, MD is currently a urologic oncology fellow at the University of California, San Francisco.  He received his undergraduate degree from Cornell University and his medical degree from the University of Maryland School of Medicine.  He completed his Urology residency at The Mount Sinai Hospital in New York.  His research interests are in identifying novel imaging tools for risk prediction in prostate cancer.

Recent Contributions to PracticeUpdate:

  1. Outcome Equivalency Between Radical Prostatectomy and Prostate Radiotherapy
  2. Biochemical Recurrence Outcomes After Radical Prostatectomy and Radiation Therapy
  3. On the Look Out for High Specificity: Identifying Significant Disease in Active Surveillance
  4. ERG Expression Associated With Increased Risk for Progression During Active Surveillance for Prostate Cancer
  5. Histologic Grade Progression of PCa Common Even With Negative Confirmatory Biopsy

Recently Updated